BIS:NSD-ProShares UltraShort Nasdaq Biotechnology (USD)

ETF | Trading--Inverse Equity | NSD

Last Closing Price

USD 26.63


-1.74 (-6.13)%

Market Cap

USD 0.01B



Average Target Price

Average Analyst Rating


Fundamental Analysis



The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price



Top Holdings


Top Sectors


Top Regions


Valuation Growth & Performance

Share Volume

Relative Performance (Total Returns)

Relative Returns (From:    To: 2020-11-27 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SQQQ ProShares UltraPro Short QQQ 0.95 %

-0.49 (-2.68%)

ZBIO ProShares UltraPro Short Nasda.. 0.95 %



ETFs Containing BIS

Symbol Name Weight Mer Price(Change) Market Cap


Market Performance

  Market Performance vs.
Industry/Classification (Trading--Inverse Equity)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Capital Gain -50.32% 100% A+ 7% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.32% 100% A+ 7% F
Trailing 12 Months  
Capital Gain -51.51% 100% A+ 6% F
Dividend Return 0.30% 50% F 4% F
Total Return -51.21% 100% A+ 6% F
Trailing 5 Years  
Capital Gain -77.07% 100% A+ 9% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -77.07% 100% A+ 8% F
Average Annual (5 Year Horizon)  
Capital Gain -22.40% N/A N/A 8% F
Dividend Return 0.48% N/A N/A 11% F
Total Return -21.92% N/A N/A 9% F
Risk Return Profile  
Volatility (Standard Deviation) 19.48% N/A N/A 71% C-
Risk Adjusted Return -112.52% N/A N/A 2% F
Market Capitalization 0.01B 50% F 5% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.